Researchers in this trial are looking to find out whether a new way of giving carboplatin chemotherapy (adaptive therapy "AT") is as safe as and more effective than the current standard way of giving carboplatin in women with advanced recurrent ovarian cancer.Recurrent ovarian cancer is usually treated with chemotherapy. The chemotherapy aims to ki…

The study aims to find out the answers to the following questions: Is one of these treatment approaches better than the other? Which treatment causes fewer side effects? Which treatment offers a better quality of life? Is it safe to use bevacizumab to treat women who are having surgery at the same time as chemotherapy? If you take …